
Neurocrine Biosciences (NBIX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Neurocrine Biosciences (NBIX) Stock
Start investing in Neurocrine Biosciences (NBIX)
About Neurocrine Biosciences (NBIX)
Market cap | $12.44B |
Yesterday's volume | 732.22K |
Revenue (TTM) | $2.41B |
Avg. daily volume | 1.43M |
EBITDA (TTM) | $529.9M |
Open | $125.42 |
Price / earnings ratio | 42.62x |
Yesterday's range | $125.42 - $127.36 |
Debt / equity | 19.45x |
52 week range | $84.23 - $157.98 |
5 year debt / equity | 20.66x |
Beta (LTM) | 0.87x |
Interest coverage | 4.72x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 3.13x |
Ex-dividend date | — |
Next earnings | Jul 31, 2025 |
Dividend payable date | — |
Neurocrine Biosciences Stock Rating
Neurocrine Biosciences Stock News
View all



Frequently Asked Questions (FAQ)
How to buy NBIX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in NBIX stock
Navigate to the Explore page. Then, type NBIX into the search bar. When you see NBIX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased NBIX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Neurocrine Biosciences Stock Earnings
The value each NBIX share was expected to gain vs. the value that each NBIX share actually gained.
Neurocrine Biosciences (NBIX) reported Q1 2025 earnings per share (EPS) of $0.70, missing estimates of $1.09 by 35.78%. In the same quarter last year, Neurocrine Biosciences's earnings per share (EPS) was $1.20. Neurocrine Biosciences is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of $1.50.